Nasopharygeal Carcinoma
Conditions
Interventions
PET/MRI scan group:N/A
Sponsors
West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Participants must have histologically or cytologically confirmednasopharygeal carcinoma 2. Clinical stage must be I-IVA (AJCC 8th ed.) 3.Age>=18 4.Participants must not have received any anti-tumor treatment before 5.ECOG performance status =1,500/mcL, platelets>=100,000/mcL,hemoglobin>=9 g/dL 7.AST(SGOT)/ALT(SGPT) =60 mL/min using the Cockcroft-Gault equation 9.Ability to understand and the willingness to sign a written informed consent document
Exclusion criteria
Exclusion criteria: 1.Age<18 2.Uncontrolled ongoing or active infection or trauma 3.Active or treated tuberculosis diagnosed within 1 year, or participants who were diagnosed with tuberculosis over 1 year but didnt received standard treatments. 4.Participants must not have known history or current diagnosis of malignancy, excluding carcinoma in situ, well-treated non-melanoma skin cancer and papillary thyroid carcinoma. 5.Known HIV-positive participants are ineligible 6.Uncontrolled illness including symptomatic congestive heart failure, unstable angina pectocariris, cardiac arrhythmia, myocardial infarction, pulmonary interstitial fibrosis, infection or psychiatric illness/social situations that would limit compliance with study requirements 7.Intolerant or allergic to 18F-FDG contrast
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Voxel signal intensity of PET/MRI; | — |
Countries
China
Contacts
Public ContactShu Zhang
West China Hospital, Sichuan Unviersity
Outcome results
None listed